Cambridge Antibody Technology reports positive initial results from CAT-152 trial Sep. 7, 1999 No Comments
NOS-2 inhibition with aminoguanidine prevents vision loss in rat model of glaucoma Sep. 6, 1999 No Comments
KeraVision receives FDA approval to complete enrollment for phase IIIb Intacs trial Sep. 1, 1999 No Comments
Ciba Vision and QLT PhotoTherapeutics seek approval for Visudyne in U.S., Switzerland Aug. 19, 1999 No Comments
RSS